BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Fortitude Group, Inc. Announces Master Funding Agreement With OTCBB Company


2/21/2014 8:59:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ERIE, PA--(Marketwired - March 04, 2014) - Fortitude Group, Inc. (OTC: FRTD) is pleased to announce that on February 28, 2014, the Company entered into a master funding agreement whereby, under the terms of the agreement, Fortitude will become the majority shareholder of a fully reporting Bulletin Board public company for the specific purpose of completing the funding of PRIMARQ while not diluting the current share structure of Fortitude.

Thomas J. Parilla, CEO of Fortitude, stated, "Under the preliminary terms of our purchase agreement, we have committed to invest $4 million USD for a 45% stake in PRIMARQ. If we were to use the equity of Fortitude to perfect this transaction, even at today's closing price, the dilution to our shareholders would be massive. To combat this, our partners at G3 designed this unique funding strategy which upon completion will allow us to acquire control of this fully reporting trading company. Instead of diluting Fortitude, we do the opposite strategy and issue our shareholders a dividend in this fully reporting company which upon closing, will give us the ability to complete the PRIMARQ investment within 30-days."

The agreement calls for closing this acquisition on or before March 7, 2014, at which time the Company will announce to the public, the name and symbol of the new publicly traded portfolio company. The release will further outline the dividend ratio to be issued to Fortitude shareholders as well as the effective date for this dividend.

About
Fortitude Group, Inc. is a diversified company with investments in multiple sectors of the economy targeting joint ventures, wholly owned subsidiaries and/or majority/minority positions that cross various market segments with the goal of creating a quality company that builds intrinsic value for its shareholders.

Forward Looking Statements
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.


Contact
Fortitude Group, Inc.
Investor Relations
Phone: 888-531-4931
Email: infofrtd@gmail.com



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES